Journal article icon

Journal article

Biliary tract and liver complications in polycystic kidney disease

Abstract:

Polycystic liver disease is a well-described manifestation of autosomal dominant polycystic kidney disease (ADPKD). Biliary tract complications are less well-recognised. We report a 50-year single-centre experience of 1,007 patients, which raised a hypothesis that ADPKD is associated with biliary tract disease. This was then tested using all-England Hospital Episode Statistics data (1998-2012) within which 23,454 people recorded as having ADPKD and 6,412,754 hospital controls were identified. Hospitalisation rates for biliary tract disease, serious liver complications and a range of other known ADPKD manifestations were adjusted for potential confounders and then compared. Compared to non-ADPKD hospital controls, the rates of admission for biliary tract disease were 2.2-times higher in those with ADPKD (rate ratio [RR] 2.24, 95% confidence interval 2.16-2.33) and 4.7-times higher for serious liver complications (RR 4.67, 4.35-5.02). When analyses were restricted to those on maintenance dialysis or with a kidney transplant, RRs attenuated substantially, but ADPKD remained positively associated with both biliary tract disease (RR 1.19, 1.08-1.31) and with serious liver complications (RR 1.15, 0.98-1.33). The ADPKD versus non-ADPKD hospital control RRs for biliary tract disease were larger for men than women (heterogeneity p<0.001), but RRs for serious liver complications appeared higher in women (heterogeneity p<0.001). The absolute excess risk of biliary tract disease associated with ADPKD (0.73%/year) was larger than for serious liver disease (0.24%/year), cerebral aneurysms (0.11%/year), or inguinal hernias (0.11%/year), but less than for urinary tract infections (2.20%/year). Biliary tract disease appears to be a distinct and important extra-renal complication of ADPKD.

Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1681/ASN.2017010084

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Population Health
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Population Health
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
NDM Experimental Medicine
Role:
Author


Publisher:
American Society for Nephrology
Journal:
Journal of the American Society of Nephrology More from this journal
Volume:
28
Issue:
9
Pages:
2738-2748
Publication date:
2017-05-02
Acceptance date:
2017-03-25
DOI:
EISSN:
1533-3450
ISSN:
1046-6673


Keywords:
Pubs id:
pubs:690244
UUID:
uuid:f372e8cb-91ad-4fff-b4dd-045397c08053
Local pid:
pubs:690244
Source identifiers:
690244
Deposit date:
2017-04-20

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP